Comparison Chart Otsuka Holdings Co., Ltd.

4578

JP3188220002

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	OTSUKA HOLDINGS CO., LTD.	Generic Pharmaceuticals	+0.44%	+3.42%	+7.21%	+4.96%	+109.17%	31.09B

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-12-09 am EST			5-day change	1st Jan Change
9,220.00 ^JPY	+0.44%		+3.42%	+7.21%

Nov. 25	Otsuka Wins U.S. FDA Accelerated Approval for VOYXACT	MT
Nov. 25	Otsuka Holdings Co receives FDA accelerated approval for Voyxact for proteinuria reduction in adults with primary immunoglobulin A nephropathy at risk for disease progression	RE

Comparison Chart Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Pharmaceuticals

Compared values

Technical Rankings Surperformance